BIO-RAD LABORATORIES, INC. Finance Lease, Right-of-Use Asset, Accumulated Amortization
BIO-RAD LABORATORIES, INC. (BIO.B) had Finance Lease, Right-of-Use Asset, Accumulated Amortization of $6.50 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Leases › Assets and Liabilities, Lessee › Finance Lease, Right-of-Use Asset, after Accumulated Amortization
us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization · last filed 2026-08-04
- 2026-06-30: Finance Lease, Right-of-Use Asset, Accumulated Amortization $6.50M.
- 2026-03-31: Finance Lease, Right-of-Use Asset, Accumulated Amortization $6.40M.
- 2025-12-31: Finance Lease, Right-of-Use Asset, Accumulated Amortization $6.40M.
- 2025-09-30: Finance Lease, Right-of-Use Asset, Accumulated Amortization $6.30M.
| Period end | Finance Lease, Right-of-Use Asset, Accumulated Amortization |
|---|---|
| 2026-06-30 | $6.50M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $6.40M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $6.40M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $6.30M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $6.60M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $6.40M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $6.10M 10-Q · filed 2025-10-29 |
| 2024-09-30 | $6.20M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $6.00M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $5.90M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $5.90M 10-Q · filed 2024-10-31 |
| 2023-09-30 | $5.70M 10-Q · filed 2023-10-27 |
| 2023-06-30 | $5.70M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $5.60M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $5.50M 10-Q · filed 2023-10-27 |
| 2022-09-30 | $5.30M 10-Q · filed 2022-10-28 |
| 2022-06-30 | $5.20M 10-Q · filed 2022-07-29 |
| 2022-03-31 | $5.20M 10-Q · filed 2022-04-29 |
| 2021-12-31 | $5.10M 10-Q · filed 2022-10-28 |
| 2021-09-30 | $5.40M 10-Q · filed 2021-10-29 |
| 2021-06-30 | $5.30M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $5.10M 10-Q · filed 2021-04-30 |
| 2020-12-31 | $5.00M 10-Q · filed 2021-10-29 |
| 2020-09-30 | $4.60M 10-Q · filed 2020-10-30 |
| 2020-06-30 | $4.40M 10-Q · filed 2020-07-31 |
| 2019-12-31 | $4.20M 10-K · filed 2021-02-16 |